sch 42495 has been researched along with Ventricular Dysfunction, Left in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Espiner, EA; Lainchbury, JG; Nicholls, MG; Richards, AM; Yandle, TG | 1 |
1 trial(s) available for sch 42495 and Ventricular Dysfunction, Left
Article | Year |
---|---|
Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Cyclic GMP; Drug Synergism; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Neprilysin; Protease Inhibitors; Renin; Ventricular Dysfunction, Left | 1999 |